Sivik Global Healthcare LLC Bio N Tech Se Transaction History

Sivik Global Healthcare LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$88.96 - $112.35 $2.22 Million - $2.81 Million	25,000 New	25,000 $2.31 Million
Q4 2022 Feb 08, 2023	BUY	$118.43 - $186.05 $1.54 Million - $2.42 Million	13,000 New	13,000 $1.95 Million
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $1.23 Million - $1.86 Million	-10,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$126.25 - $231.85 $1.26 Million - $2.32 Million	10,000 New	10,000 $1.71 Million
Q2 2021 Aug 10, 2021	SELL	$113.32 - $241.49 $2.27 Million - $4.83 Million	-20,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$85.73 - $119.5 $1.71 Million - $2.39 Million	20,000 New	20,000 $2.18 Million
Q3 2020 Nov 13, 2020	SELL	$57.81 - $104.17 $2.31 Million - $4.17 Million	-40,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $1.54 Million - $2.67 Million	40,000 New	40,000 $2.67 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.